43
total announcements
543220.BO · 15 min delayed
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced a schedule for an earnings call for investors and analysts to discuss Q2 & H1 FY27 results on November 3, 2026.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has scheduled a Board Meeting on October 30, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has informed about the approval of Performance Linked Restricted Stock Unit Scheme 2026 and grant of Performance Linked Restricted Stock Units to eligible employees through postal ballot. The company has also altered its main objects clause in the Memorandum of Association.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced the voting results and scrutinizer's report on its postal ballot, where shareholders have passed four special resolutions, including the approval of the 'Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026' and the grant of Performance Linked Restricted Stock Units to eligible employees.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced the voting results and scrutinizer's report on its postal ballot. The company's shareholders have passed four special resolutions, including the approval of a Performance Linked Restricted Stock Unit Scheme 2026 and the grant of Performance Linked Restricted Stock Units to eligible employees. The resolutions were passed with a high percentage of votes in favour, with the total number of votes polled being 97,33,10,251.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has received an ESG rating of '66' for FY 2025-26 from NSE Sustainability Ratings and Analytics Limited, an independent SEBI-registered ESG rating provider, based on the company's public disclosures.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced that CARE Ratings Limited has upgraded the credit rating for its wholly-owned material subsidiary, Crosslay Remedies Limited, to CARE AA+ with a stable outlook.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has received a reaffirmation of its credit rating by CARE Ratings Limited, with its long-term bank facilities rated at CARE AA+ and short-term bank facilities rated at CARE A1+.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has received a certificate from MUFG Intime India Private Limited, confirming that no requests for dematerialization of shares were received during the quarter ended September 30, 2026.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has received an order from the Hon'ble National Company Law Tribunal, Cuttack Bench, adjourning the matter to October 29, 2026, for further hearing on petitions filed by BRS Capital against Kalinga Hospital Ltd, a subsidiary of the Company.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced the closure of its trading window for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has published a newspaper advertisement regarding a postal ballot notice for seeking approval of members through remote e-voting for four special resolutions.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced a postal ballot notice for shareholders to approve various business resolutions, including the grant of performance-linked restricted stock units to employees and the alteration of the main objects clause of the Memorandum of Association.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced the newspaper publication in Form INC-26 regarding the shifting of its Registered office.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has received a communication from Kalinga Hospital Ltd confirming the allotment of 50,21,212 equity shares to the Company on a rights basis, increasing the Company's shareholding in KHL from ~58.28% to ~66.15%.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has allotted 33,765 equity shares to eligible employees under the Employee Stock Option Scheme 2022. The paid-up equity share capital of the Company stands increased to 97,33,10,251.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced the infusion of ₹87.87 Crore in its subsidiary Kalinga Hospital Ltd through a rights issue to support its capital expenditure and modernization programme.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has inaugurated a new 400 beds tower at its Max Smart Super Speciality Hospital in Saket, Delhi, increasing its total capacity to approximately 1,200 beds.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has received a show cause cum demand notice from the Office of the Pr. Additional Director General, Mumbai Zonal Unit, Directorate General of Goods & Services Tax Intelligence for alleged non-payment of GST on variable management fee by Alps Hospital Limited, a wholly-owned subsidiary of the Company. The notice demands ₹55,23,52,071/- and applicable interest, and penalty under Section 74(1) and 74A(5)(ii) of the Central Goods and Services Tax Act, 2017.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd held an earnings call on August 14, 2026, to discuss its Q1 FY27 financial results, which showed a 16% year-on-year growth in revenue and 15% in operating EBITDA. The company also announced several new initiatives, including the integration of Max Bhubaneswar into the network, the acquisition of a new brownfield tower at Max Vaishali, and the establishment of a standalone Max Research Centre. Additionally, the company received in-principle approval from the board to embark on the medical education business.